I don't think the short exit is mainly going to do it... not often a billion dollar startup has a binary yes will be successful or not outcome. I think the buying pressure from everyone else will far outweigh the shorts. Not many other.. infact no other biotech on ASX with the phase 3 opportunity pool msb has.
Remember as Reg says, first cab off the ramp will be expansion into adult trial, which is a 6 - 9x market value than pediatric.
Concurrently the CLBP has over 1,000 times the number of patients alone, than pediatric sr gvhd, and MSB have been busy updating their bioreactor , bovine free serum patents. The yields are better than with FBS according to the patent.
Approval means rapid pathway to greatness.
I don't think the short exit is mainly going to do it... not...
-
- There are more pages in this discussion • 647 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |